<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02679222</url>
  </required_header>
  <id_info>
    <org_study_id>2016-541</org_study_id>
    <nct_id>NCT02679222</nct_id>
  </id_info>
  <brief_title>Comparing the Ketogenic Effect of Coconut Oil and Different MCTs</brief_title>
  <acronym>Coco-MCT</acronym>
  <official_title>Comparing the Ketogenic Effect of Coconut Oil and Different Medium-chain Triglycerides</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Sherbrooke</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Université de Sherbrooke</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the ketogenic effect of coconut oil and three MCT oils
      (60-40 , tricaprylin and triheptanoate) on the production of ketones in healthy adults. Each
      oil are evaluated individually or in combination over a 8h-period during which repeated blood
      sampling is performed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is composed of eight successive visits. Each visit consists of the consumption of
      one individual oil or a mixture of oils (20 g of coconut oil or 10 g of coconut oil + 10 g of
      MCT 60-40 or 20 g MCT 60-40 or 10 g coconut oil + 10 g tricaprylin or 20 g tricaprylin or 10
      g coconut oil + 10 g triheptanoate or 20 g triheptanoate) and a 8h follow-up during which
      repeated blood samples are taken for laboratory analysis (plasma beta-hydroxybutyrate,
      acetoacetate, glucose, free fatty acids, triglycerides, total cholesterol, lactate and
      insulin).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2015</start_date>
  <completion_date type="Actual">March 1, 2017</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma ketone concentrations</measure>
    <time_frame>8 hours</time_frame>
    <description>Acetoacetate (uM) and beta-hydroxybutyrate (uM)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma glucose concentrations</measure>
    <time_frame>8 hours</time_frame>
    <description>Glucose (mM)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma cholesterol concentrations</measure>
    <time_frame>8 hours</time_frame>
    <description>Total cholesterol (mM)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma free fatty acid concentrations</measure>
    <time_frame>8 hours</time_frame>
    <description>Triglycerides (mM)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma triglyceride concentrations</measure>
    <time_frame>8 hours</time_frame>
    <description>Triglycerides (mM)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma insulin concentrations</measure>
    <time_frame>8 hours</time_frame>
    <description>Insulin (IU/L)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Healthy Adults</condition>
  <arm_group>
    <arm_group_label>Supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral intake of one of the supplements: 20 g of coconut oil or 10 g of coconut oil + 10 g of MCT 60-40 or 20 g MCT 60-40 or 10 g coconut oil + 10 g tricaprylin or 20 g tricaprylin or 10 g coconut oil + 10 g triheptanoate or 20 g triheptanoate</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Supplementation</intervention_name>
    <description>coconut oil and MCT oils (60-40, tricaprylin and triheptanoate)</description>
    <arm_group_label>Supplementation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy adult over 18 y old.

        Exclusion Criteria:

          -  Fasting plasma glucose ≥7.0 mM (diabetics or pre-diabetics);

          -  Smoking

          -  Clinically-significant gastro-intestinal disease/conditions.

          -  Clinically-significant liver disease/dysfunction.

          -  Clinically-significant cardiac disease/conditions.

          -  Clinically-significant abnormal coagulation.

          -  Taking a medication that could affect lipid and glucose metabolism

          -  Hypertension

          -  Pregnancy or breastfeeding

          -  Exercising more than 3 times a week
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen Cunnane, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CSSS-IUGS - CIUSSS de L'Estrie - CHUS - Université de Sherbrooke</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Centre on Aging (CSSS-IUGS - CIUSSS de l'Estrie - CHUS)</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H4C4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2016</study_first_submitted>
  <study_first_submitted_qc>February 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2016</study_first_posted>
  <last_update_submitted>March 27, 2017</last_update_submitted>
  <last_update_submitted_qc>March 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

